SpringerProtocols: Abstract: Purinergic Receptors in the CNS

Purinergic Receptors in the CNS

By: Michael Williams¹

Abstract

Full Text

Download PDF (3285K)

The phenomenon of “nonadrenergic, noncholinergic” neurotransmission in the mammalian peripheral nervous system probably involves the mediation of the purines, adenosine and its nucleotide, ATP (Burnstock, 1972, 1983).

Affiliation(s): (1) Pharmaceutzcals Diviszon, Neurosciences Research, CUBA-GEIGY Corporation, Summit, New Jersey, USA

Book Title: Receptor Binding

Series: Neuromethods | Volume: 4 | Pub. Date: Jun-20-1986 | Page Range: 365-413 | DOI: 10.1385/0-89603-078-4:365

Subject: Neuroscience

References

Download References

Arch J. R. S. and Newsholme E A (1978) The control of metabolism and the hormonal role of adenosine Essays Biochem 14, 82–123

Arnanada J V. and Turmen T. (1979) Methylxanthines in apnea of prematurity Clin Perinatol 6, 87–108

Arvidsson S B, Ekstrom-Jodal B., Martmell S A G, and Niemand D (1982) Aminophylline antagonizes diazepam sedation. Lancet ii, 1467

Baud-Lambert J., Marwood J. F., Davies L. P., and Taylor K. M. (1980) I-methyllsoguanosine. an orally active marine natural product with skeletal muscle and cardiovascular effects. Life. Sci 26, 1069–1077.

Baker P F (1972) Transport and metabolism of calcium ions in nerve Prog Biophys Mol Biol 24, 177–224.

Barnes E M. and Thampy K. G (1982) Subclasses of adenosine receptors in brain membranes from adult tissue and from primary cultures of chick embryo J Neurochem 39, 647–652.

Barraco R. A., Coffin V L., Altman H J, and Phillis J W (1983) Central effects of adenosine analogs and locomotor activity in mice and antagonism by caffeine Brain Res 272, 392–395

Barraco R. A., Aggarwal A K., Phillis J W., Moore M A., and Wu P. H (1984) Dissociation of the locomotor and hypotensive effects of adenosine analogs in the rat. Neurosci Lett. 48, 139–144.

Belardinelli L, West A, Crampton R, and Berne R. M (1983) Chronotropic and Dromotropic Effects of Adenosme, in Regulatory Function of Adenosine (Berne R M., Rall T W, and Rubio R, eds.) pp 377–398, Martinus Nijhoff, Boston

Bender A. S., Wu P H., and Phillis J. W. (1981) The rapid uptake and release of [³H]-adenosine by rat cerebral cortical synaptosomes J Neurochem. 36, 651–660.

Berne R. M. (1980) The role of adenosine in the regulation of coronary blood flow. Circ. Res. 46, 807–813.

Berne R. M., Knabb R. M., Ely S. W., and Rubio R. (1983a) Adenosine in the local regulation of blood flow: a brief overview. Fed. Proc 42, 3136–3142.

Berne R. M., Rail T. W., and Rubio R. (1983b) Regulatory Function of Adenosine. Martmus Nijhoff, Boston.

Boulenger J-P., Patel J., Post R M., Parma A., and Marangos P J (1983) Chronic caffeine consumption increases the number of brain adenosine receptors. Life Sci 32, 1135–1142.

Braestrup C., Nielsen M., and Olsen C. E (1980) Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors Proc. Natl. Acad. Sci. USA 77, 2288–2292

Browne R. G. and Welch W. M. (1982) Steroselective antagonism of phencychdine’s discriminative properties by adenosine receptor agonists. Science 217, 1157–1158.

Bruns R. F (1980) Adenosine receptor activation in human fibroblasts Nucleoside agonists and antagonists. Can. J. Physiol. Pharmacol. 58, 673–691.

Bruns R F (1981) Adenosine antagonism by purines, pteridines, and benzopteridines in human fibrobasts. Biochem Pharmacol. 30, 325–333.

Bruns R. F., Daly J. W., and Snyder S. H. (1980) Adenosine receptors in brain membranes binding of N⁶-cyclohexyl-[³H]-adenosine and 1,3-diethyl-8-[³H]-phenylxanthine. Proc. Natl. Acad. Sci USA 77, 5547–5551

Bruns R. F, Daly J W., and Snyder S. H. (1983a) Adenosine receptor binding. structure activity analysis generates extremely potent xanthine antagonists. Proc. Natl Acad. Sci. USA 80, 2077–2080

Bruns R. F., Katims J. J., Annau Z., Snyder S. H., and Daly J. W. (1983b) Adenosine receptor interactions and anxiolytics. Neuropharmacol 22, 1523–1529.

Burnstock G. (1972) Purinergic nerves. Pharmacol Rev 24, 509–581.

Burnstock G. (1978) A Basis for Distinguishing Two Types of Purinergic Receptors, in Cell Membrane Receptors for Drugs and Hormones (Bolis L, and Straub R. N., eds.) pp 107–118, Raven Press, New York.

Burnstock G. (1981) Pathophysiology of migraine a new hypothesis Lancet ii, 1397–1399

Burnstock G. (1983) A Comparison of Receptors for Adenosine and Adenine Nucleotides, in Regulatory Function of Adenosine (Berne R M, Rall T. W, and Rubio R., eds.) pp. 49–62, Martinus Nijhoff, Boston

Burnstock G. and Buckley N. J. (1985) The Classification of Receptors for Adenosine and Adenine Nucleotides, in Methods in Pharmacology 6, Methods Used In Adenosine Research. (Paton D. M., ed.) Plenum, New York.

Burnstock G. and Hoyle C. H. V (1985) PACPX—a substituted xanthine—antagonizes both the A₁ and A₂ subclasses of the P1 purinoceptor. antagonism of the A₂ subclass is competitive but antagonism of the A₁ subclass is not Brit J Pharmacol, 85, 291–296

Carlsson A (1975) Receptor-Mediated Control of Dopamine Metabolism, in Pre-and Postsynaptic Receptors (Usdin E and Bunney W E, Jr, eds.) pp 49–67, Marcel Dekker, New York.

Charney P. S., Galloway M. P., and Heninger G R. (1984) The effects of caffeine on plasma MHPG, subjective anxiety, autonomic symptoms, and blood pressure in healthy humans Life Sci 35, 135–144

Coffin V. C. and Carney J. M (1983) Behavioral Pharmacology of Adenosine Analogs, in Physiology and Pharmacology of Adenosine Derivatives (Daly J. W., Kuroda Y., Phillis J. W., Shimizu H, and Ui M., eds) pp 267–274, Raven, New York.

Coffin V. C., Taylor J A, Phillis J. W., Altman H J, and Barraco R A (1984) Behavioral interaction of adenosine and methylxanthines on central purinergic systems Neurosci. Lett, 47, 91–98.

Collier H O. J. and Tucker J F. (1983) Novel form of drug-dependence—on adenosine in guinea pig ileum Nature (Lond.) 302, 618–621.

Collier H. O. J., Francis D L, Henderson G., and Schnieder C. (1974) Quasi-morphine abstinence syndrome. Nature (Lond.) 249, 471

Collier H O. J, Cuthbert N. J., and Francis D L. (1981) Character and mearung of quasi-morphine withdrawal phenomena elicited by methylxanthines Fed Proc. 40, 1513–1518

Collier H. O. J., Plant N. T., Tucker J. F., and Von Uexull A (1984) Inhibition with adenosine derivatives of opiate withdrawal effects Brit. J Pharmacol 81, 131P

Collis M G., and Brown C. M (1983) Adenosine relaxes the aorta by interacting with an A₂-receptor and an intracellular site. Eur. J Pharmacol 96, 61–69

Cooper D M. F., Londos C, and Rodbell R (1980) Adenosine receptor-mediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process. Mol. Pharmacol. 18, 598–601.

Crawley J. N., Pate1 J., and Marangos P. J. (1981) Behavioral characterization of two long lasting adenosine analogs. sedative properties and interaction with diazepam. Life Sci 29, 2623–2630.

Cuatrecasas P and Hollenberg M. (1976) Membrane receptor and hormone action Adv Protein Chem. 30, 251–451

Cubeddu L, Barnes E., and Winer N (1975) Release of norepinephrine and dopamine hydroxylase by nerve stimulation IV An evaluation of a role for cyclic AMP. J. Pharmacol. Exp Ther. 193, 105–127

Daly J. W. (1973) Role of ATP and Adenosine Receptors in Physiologic Processes: Summary and Prospectus, in Physiology and Pharmacology of Adenosine Derivatives (Daly J. W., Kuroda Y, Phillis J. W., Shimizu H., and Ui M, eds.) pp. 275–290, Raven, New York

Daly J W (1977) Cyclic Nucleotides in the Nervous System. Plenum, New York.

Daly J.W. (1982) Adenosine receptors target sites for drugs J.Med Chem 25, 197–207.

Daly J. W. (1983) Binding of Radioactive Ligands to Adenosine Receptors in the Central Nervous System, in Regulatory Function of Adenosine. (Berne R. M., Rall T W., and Rubio R, eds) pp. 97–113, Martinus Nijhoff, Boston

Daly J. W., Bruns R. F., and Snyder S H (1981) Adenosine receptors in the central nervous system: Relationship to the central actions of methylxanthines. Life Sci 28, 2083–2097.

Daly J W, Butts-Lamb P, and Padgett W (1983) Subclasses of adenosine receptors in the central nervous system interaction with caffeine and related methylxanthines Cell Mol. Neurobiol. 3, 69–80

Daly J W., Mimitkitpaisan Y., Pons F., Bruns R F., Smellie F., and Skolnick P (1979) Binding sites for adenosine analogs: Possible relationship to cyclic-AMP generating systems in brain tissue Pharmacologist 21, 253

Dar M. S., Mustafa S. J., and Wooles W. R (1983) Possible role of adenosine in the CNS. Effects of ethanol. Life Sci 33, 1363–1374.

Davies L P, Cook A F, Poonian M., and Taylor K. M. (1980) Displacement of [³H]-diazepam binding in rat brain by dipyridamole and by 1-methylisoguanosine, a marine natural product with muscle-relaxant activity Life Sci. 26, 1089–1094.

Davies L. P., Brown D. J., Chen Chow S., and Johnston GAR (1983) Pyrazolo [3,4-D]-pyrimidines, a new class of adenosine antagonists. Neurosci. Lett 41, 189–194.

Davies L. P., Chow S. C., and Johnston G A. R. (1984) Interaction of purines and related compounds with photoaffinity-labeled benzodlazepine receptors in rat brain membranes Eur J. Pharmacol 97, 325–329.

de Mazancourt P. and Giudicelli Y. (1984) N⁶-Phenyhsopropyladenosine stimulates in normal and inhibits in adrenalectomized rats the low Km cyclic AMP phosphodiesterase in brain. Brain Res. 300, 211–217

Dolphin A. C. and Archer E R. (1983) An adenosine agonist inhibits and a cyclic AMP analogue enhances the release of glutamate but not GABA from slices of rat dentate gyrus. Neurosci. Lett. 43, 49–54

Drury A. N. and Szent-Gyorgi A (1929) The physiological activity of adenine compounds with especial reference to then actions upon the mammalian heart J Physiol. (Lond.) 68, 213–237.

Dunwiddie T. V. (1980) Endogenously released adenosine regulates excitability in the in vitro hippocampus. Epilepsia 21, 541–548.

Dunwiddie T. V. and Hoffer B. J (1980) Adenine nucleotides and synaptic transmission in the in vitro rat hippocampus. Brit. J. Pharmacol. 69, 59–68

Dunwiddie T. V., Hoffer B. J and Fredholm B. B (1981) Alkylxanthines elevate hippocampal excitability. evidence for a role for endogenous adenosine. Naunyn-Schmeideberg’s Arch. Pharmacol. 316, 326–330.

Dunwiddie T. V. and Worth T (1982) Sedative and anticonvulsant effects of adenosine analogs in mouse and rat. J. Pharmacol Exp Ther. 220, 70–76.

Dunwiddie T. V, Basile A. S., and Palmer M. R. (1984) Electrophysiological responses to adenosine analogs in rat hippocampus and cerebellum Evidence for mediation by adenosine receptors of the A-1 subtype Life Sci 34, 34–47

Ebersolt C, Premont J., Prochiantz A., Perez M, and Bockaert J. (1983) Inhibition of brain adenylate cyclase by A₁-adenosine receptors pharmacological characteristics and location. Brain Res. 267,123–124.

Ebstein R. P. and Daly J W. (1982) Release of norepinephrine and dopamine from brain vesicular preparations effects of adenosine analogs. Cell Mol Neurobiol 2, 193–204.

Edvinsson L. and Fredholm B. B. (1983) Characterization of adenosine receptor in isolated cerebral arteries of cat Brit J. Pharmacol 80, 631–637

Elliott J, Jhamandas K, Notman H, and Sutak M (1983) Antagonism of enkephalin action on acetylcholine release by methylxanthine. lack of a purine link Brit. J Pharmacol. 80, 727–734

Farah A. E., Alousi A. A., and Schwarz, Jr. R. P (1984) Positive inotropic agents Ann Rev Pharmacol Toxicol 24, 275–328.

Feldberg W. and Sherwood S L (1954) Injections of drugs into lateral ventricle of the cat. J Physiol. (Lond.) 123, 148–167.

Ferkany J. W., Valentine H., Stone G, and Williams M. (1986) Adenosine A-1 receptors in mammalian brain: Species differences in their interactions with agonists and antagonists J. Neurochem., submitted.

Fox I H. and Kurpis L. (1983) Binding characteristics of an adenosine receptor in human placenta J Biol Chem 258, 6952–69551

Fredholm B. B. (1982a) Adenosine receptors Med Biol. 60, 289–293

Fredholm B. B. (1982b) Characterization of adenosine receptors in the brain. Acta Physiol Scand. Suppl. 508, 31

Fredholm B. B and Vernet L. (1978) Morphine increases depolarization-induced purine release from rat cortical slices Acta Physiol. Scand 104, 502–504

Fredholm B. B and Hedqvist P (1980) Modulation of neurotransmission by purine nucleotides and nucleosides. Biochem. Pharmacol. 29, 1635–1643.

Fredholm B. B. and Persson C G. A. (1982) Xanthine derivatives as adenosine receptor antagonists Eur J Pharmacol 81, 673–676

Fredholm B B., Jonzon B, Lindgren E., and Lindstrom K. (1982) Adenosine receptors mediating cyclic AMP production in the rat hippocampus. J Neurochem 39, 165–175.

Fredholm B. B., Dunwiddie T V., Bergman B., and Lindsham, K (1984) Levels of adenosine and adenine nucleotides in slices of rat hippocampus. Brain Res. 295, 127–136.

Frew R. and Lundy P. M (1982) Effect of arylazido aminopropionyl ATP (ANAPP₃), a putative ATP antagonist, on ATP responses of isolated guinea pig smooth muscle Life Sci. 30, 259–267.

Galloway M. P and Roth R. H. (1983a) Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain J Neurochem. 40, 246–251.

Galloway M. P. and Roth R H (1983a) Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain J Neurochem. 40, 246–251.

Galloway M P and Roth R H (1983b) Neuropharmacology of 3-isobutylmethylxanthine. effect on central noradrenergic systems in vivo. J. Pharmacol Exp. Ther. 227, 1–8.

Gavish M., Goodman R R., and Snyder S H (1982) Solubilized adenosine receptors in the brain. regulation by guanine nucleotrdes Science 215, 1633–1635.

Gold M. S, Pottash A. C., Sweeney D. R., and Kleber H. D. (1980) Opiate withdrawal using clonidine A safe, effective, and rapid non-opiate treatment J Am Med Assoc. 243, 343–346.

Goldberg A. L. and Singer J. J. (1969) Evidence for a role of cyclic AMP in neuromuscular transmission. Proc. Natl. Acad. Sci. USA 64, 134–141.

Goldberg M. R., Curatolo P W., Tung C. S., and Robertson D (1982) Caffeine down-regulates beta adrenoceptors in rat forebrain. Neurosci. Lett. 31, 47–52.

Goodman R R and Snyder S H (1982) Autoradiographic localization of adenosine receptors in rat brain using [³H]cycIohexyladenosine J Neurosci. 2, 1230–1241.

Goodman R. R., Cooper M. J, Gavish M, and Snyder S H (1982) Guanme nucleotide and cation regulation of the binding of [³H]-cyclohexyladenosine and [³H]diethylphenylxanthine to adenosine receptors in brain membranes. Mol Pharmacol 211, 329–335

Goodman R. R., Kuhar M J., Hester L., and Snyder S H. (1983) Adenosine receptors. autoradiographic evidence for their location on axon terminals of excitatory neurons Science 220, 967–969.

Grant S. J. and Redmond D E. (1982) Methylxanthine activation of noradrenergic unit activity and reversal by clondine. Eur J. Pharmaco1 85, 1054–109

Green H N and Stoner H B (1950) Biological Actions of the Adenosine Nucleotides Lewis, London

Green R D, Proudfit H. K, and Yeung S-M. H.(1982) Modulation of striatal dopaminergic function by injection of 5′-N-ethylcarboxamide adenosine Science 218, 58–61.

Guroff G., Dickens G., End D., and Londos C. (1981) The action of adenosine analogs on PC 12 cells. J. Neurochem. 37, 1431–1439.

Hamprecht B. and Van Calker D. (1985) Nomenclature of adenosine receptors. Trends Pharmacol. Sci. 6, 153–154.

Harms H. H., Wardeh G., and Mulder A H. (1978) Adenosine modulates depolarization-induced release of [³H]noradrenaline from slices of rat brain neocortex Eur J. Pharmacol 49, 305–308.

Harms H. H, Wardeh G., and Mulder A. H. (1979) Effects of adenosine depolarization-induced release of various radiolabeled neurotransmitters from slices of rat corpus striatum. Neuropharmacol 18, 577–880

Hartzell C H. (1979) Adenosine receptor in frog sinus venosus slow inhibitory potentials produced by adenine compounds and acetyl-choline. J Physiol. (Lond.) 293, 23–49

Haslam R. J., Davidson M. M L., and Desjardins J. W (1978) Inhibition of adenylate cyclase by adenosine analogs in preparations of broken and intact human platelets. Biochem J 176, 83–95

Haubrich D. R., Williams M, Yarbrough G. G, and Wood P L. (1981) 2-chloroadenosine inhibits brain acetylcholine turnover. Can J Physiol Pharmacol. 59, 897–1020

Haulica I., Aradei L, Bransteau D., and Topoliceanu F. (1973) Preliminary data on the possible hypnogenic role of adenosine. J Neurochem 21, 1019–1020

Hazeki O, Katada T., Kurose H., and Ui M. (1983) Effect of Adenosine on Cyclic AMP Accumulation in Cardiac and Other Cells and Its Modification by Islet-Activating Protein, in Physiology and Pharmacology Of Adenosine Derivatives. (Daly J W., Phillis J. W, Kuroda Y, Shimizu H., and Ui M., eds ) pp 41–49, Raven, New York

Hedner T., Hedner J., Wessberg P, and Jonason J (1982) Regulation of breathing in the rat indications for a role of central adenosine mechanisms. Neurosci Lett. 33, 147–151.

Henon B A and McAfee D A (1983) The ionic basis of adenosine receptor actions of postsynaptic neurones in the rat J. Physiol (Lond) 336, 607–620

Hogaboom G. K., O’Donnell J. P., and Fedan J. S (1980) Purinergic receptors photoaffinity analog of adenosine triphosphate is a specific adenosine triphosphate antagonist Science 208, 1273–1276

Hollins C. and Stone T W. (1980) Adenosine inhibition of γ-ammobutyric acid release from slices of rat cerebral cortex. Brit. J Pharmacol 69, 107–112

Hrdina P. D. (1985) Introduction in Neuromethods IV Receptor Binding (Boulton A A., Baker G. B, and Hrdina, P D., eds.) Humana, Clifton, New Jersey

Huang, M. and Daly J. W (1974) Adenosine-elicited accumulation of cyclic AMP in brain slices potentiation by agents which inhibit uptake of adenosine. Life Sci. 14, 489–503.

Hunt S. P. and Kunzle H (1976) Bidirectional movement of label and transneuronal transport phenomena after inlection of [³H]adenosine in the central nervous system. Brain Res. 112, 127–132

Israel M., Lesbats B., Manaranche R., Muemer F. M., and Franchon P. (1980) Retrograde inhibition of transmitter release by ATP. J Neurochem. 34, 923–932.

Jahr C. E. and Jesse1 T M (1983) ATP excites a subpopulation of rat dorsal horn neurons Nature (Lond.) 304, 730–732.

Jhmandas K. and Dumbrille A. (1980) Regional release of [³H]adenosine derivatives from rat brain in vivo effect of excitatory amino acids, opiate agonists, and benzodiazepines. Can. J. Physiol. Pharmacol. 58, 1262–1278.

Kakiucki S., Rall T. W., and McIlwam H. (1968) The effect of electrical stimulation upon the accumulation of adenosine 3′,5′-phosphate in isolated cerebral tissue. J. Neurochem. 16, 485–491.

Katims J. J., Annau Z., and Snyder S. H. (1983) Interactions in the behavioral effects of methylxanthines and adenosine derivatives. J. Pharmacol. Exp Ther 227, 167–173

Kelley W. N. (1983) Disorders of Nucleic Acid Metabolism, in Principles of Internal Medicine. (Petersdorf R. G., Adams R. A., Braunwald E., Isselbacher K. J., Martin J. B., and Wilson J. D., eds.) pp. 517–524, McGraw-Hill, New York

Kenakin T. P (1982) The potentiation of cardiac responses to adenosine by benzodiazepines. J Pharmacol. Exp. Ther. 222, 752–758.

Kluge H., Hartmann W., Wieczorek V, and Zahlten W (1972) Kinetic properties of cerebral 5′-nucleotidase. J. Neurochem. 19, 1409–1411.

Kobayashi K., Kuroda Y, and Yoshioka M. (1981) Change of cyclic AMP level in synaptosomes from cerebral cortex increase by adenosine derivatives. J. Neurochem. 36, 86–91.

Kuba M. L., Kato E., Kumamoto E., Koketsu K, and Hirai K. (1981) Sustained potentiation of transmitter release by adrenaline and dibutyryl cyclic AMP in sympathetic ganglia Nature (Lond ) 291, 654–656.

Kulkarni S. K. and Mehta A K (1984) P₁-purinoceptor antagonism by clonidine in the rat caecum. Life Sci. 34, 2273–2277.

Kuroda Y. (1978) Physiological roles of adenosine derivatives which are released during neurotransmission in mammalian brain. J Physiol. (Paris) 74, 463–470.

Kuroda Y, and McIlwain H. (1973) Subcellular localization of [¹⁴C]adenine derivative newly formed in cerebral tissues and the effects of electrical excitation J Neurochem 21, 889–900

Kuroda Y. and McIlwain H. (1974) Uptake and release of [¹⁴C]adenine derivatives at beds of mammalian cortical synaptosomes in a superfusion system J. Neurochem. 22, 691–699

Lal R. T., Watanabe Y., Kamino Y., and Yoshida H. (1984) Interaction between 2-chloroadenosine and cx-adrenoceptors in rat vas deferens Life Sci 34, 409–418.

Lal H., Gherezghiher T., and Carney J (1983) Ineffectiveness of a purine analogue, EMD 28422, in two animal tests of anxiolytic action Drug Dev Res. 3, 75–79.

Laska E. M., Sunshine A., Mueller F, Elvers W B, Siegel C, and Rubin A. (1984) Caffeine as an analgesic adjuncant. J. Am. Med. Assoc 251, 1711–1718

Lee K, Schubert P, Gribkoff V., Sherman B., and Lynch G. (1982) A combined in vivo/in vitro study of the presynaptic release of adenosine derivatives in the hippocampus J Neurochem 28, 80–83

Lee K. S., Reddington M, Schubert P, and Kreutzberg G (1983) Regulation of the strength of adenosine modulation in the hippocampus by a differential distribution of the density of A₁ receptors. Brain Res 260, 156–159.

Levin A. S. and Morley J. E. (1983) Effect of intraventricular adenosine on food intake in rats Pharmacol Biochem Behav 19, 23–26.

Levin R. M., Jacoby R., and Wein A. J. (1983) High-affinity, divalent ion-specific binding of [³H]-ATP to homogenate derived from rabbit urinary bladder. Mol. Pharmacol 23, 1–7.

Lloyd K G., Hornykiewicz O., Davidson L, Shannak K, Farley I., Goldstein M., Shibuya M, Kelley W. N., and Fox I (1981) Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N. Eng J Med 305, 1106–1111.

Londos C. and Wolff J (1977) Two distinct adenosine-sensitive sites on adenylate cyclase. Proc. Natl. Acad Sci USA 74, 5482–5486

Londos C., Cooper D. M. F., and Wolff J. (1980) Subclasses of adenosine receptors. Proc Natl Acad Sci USA 77, 2551–2554

Londos C., Wolff J, and Cooper D. M. F. (1983) Adenosine Receptors and Adenylate Cyclase Interactions, in Regulatory Functions of Adenosine (Berne R. M., Rall T. W., and Rubio R., eds.) pp. 17–32, Martinus Nijhoff, Boston

MacDonald W F. and White T D (1984) Adenosine released from synaptosomes is derived from the extracellular dephosphorylation of released ATP Prog Neuropsychopharmacol & Biol. Psychiat 8, 487–494.

Maitre M, Ciesielski L, Lehmann A, Kempt E, and Mandell P. (1974) Protective effect of adenosine and nicotinamide against audogenic seizures. Biochem Pharmacol 23, 2807–2816.

Major P. P., Agarawal R. P., and Kufe D. W. (1981) Deoxycoformycin neurological toxicity. Cancer Chemother. Pharmacol 5, 193–196

Marangos P. J, Pate1 P., Martino A. M, Dilli M, and Boulenger J-P (1984a) Differential binding properties of adenosine receptor agonists and antagonists in brain. J. Neurochem. 41, 365–374.

Marangos P. J., Boulenger J-P, and Pate1 J. (1984b) Effects of chronic caffeine on brain adenosine receptors: regional and ontogenetic studies. Life Sci. 34, 899–907.

Marley E. and Nistico G. (1972) Effects of catecholamines and adenosine derivatives given into the brain of fowls. Brit J Pharmacol 46, 619–636.

McIlwain H. (1978) Synaptic mediation and the structuring of cerebral activity. Prog Neurobiol. 11, 189–203.

McIlah K., Harb J., Duflos Y,and Bernard, S (1984) 5 ′-Nucleotidase from bovine caudate nucleus synaptic plasma membranes specificity for substrates and cations, study of the carbohydrate moiety by glycosidases. J. Neurochem. 42, 1107–1115

Mendelson W. B., Kuruvilla A, Watlington T., Goehl K., Paul S. M., and Skolnick P. (1983) Sedative and electroencephalographic actions of erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA). Relationship to inhibition of brain adenosine deaminase Psychopharmacol 79, 126–129.

Michaelis M. L., Michaelis E. K., and Myers S. L (1979) Adenosine modulation of synaptosomal dopamine release. Life Sci 24, 2083–2092.

Morgan P. F, Lloyd H. G. E, and Stone T. W. (1983) Benzodiazepine inhibition of adenosine uptake is not prevented by benzodiazepine antagonists Eur. J. Pharmacol. 87, 121–126.

Moritaki H. (1983) Possible Mechanism of Potentiation of the Action of Adenosine by Some Vasodilators, in Physiology and Pharmacology of Adenosine Derivatives (Daly J. W., Kuroda Y., Phillis J. W., Shimizu H., and Ui M., eds.) pp. 197–207, Raven, New York.

Murphy K. M. M. and Snyder S. H. (1982) Heterogeneity of adenosine A₁ receptor binding in brain tissue. Mol. Pharmacol 21, 250–257

Murray T. F. (1982) Upregulation of rat cortical adenosine receptors following chronic administration of theophylline. Eur J Pharmacol. 82, 113–114

Murray T F. and Cheney D C (1982) Neuronal location of N⁶-cyclohexyl-[³H]-adenosine binding sites in rat and guinea pig brain. Neuropharmacol 21, 575–580

Murray T F., Blaker W D., Cheney D. L., and Costa E. (1982) Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs. J. Pharmacol Exp Ther. 222, 550–554.

Nagata H., Mimori Y,, Nakamura S., and Kameyama M. (1984) Regional and subcellular distribution in mammalian brain of the enzymes producing adenosine. J. Neurochem. 42, 1001–1007.

Nagy J. I., Labella F. S., Buss M., and Daddona P. E. (1984) Immunohistochemistry of adenosine deammase. implications for adenosine neurotransmission. Science 224, 166–168.

Nakumura S., Mimori Y., Iljima S, Nagata H., Yamao S., and Kameyama M. (1983) Distribution of Adenosine-Producing Enzymes in the Brain, in Physiology and Pharmacology of Adenosine Derivatives (Daly J. W., Kuroda Y, Phillis J. W., Shimiza H., and Ui M., eds.) pp. 21–29, Raven, New York

Newby A. C, Luzio J. P, and Hales C. N (1975) The properties and extracellular locatron of 5′-nucleotidase of the rat fat cell plasma membrane. Biochem. J 146, 625–633.

Newman M E. (1983) Adenosine binding sites in brain: relatronship to endogenous levels of adenosine and its physiological and regulatory roles. Neurochem. Inter. 5, 21–35.

Newman M. E. and McIlwain H. (1977) Adenosine as a constituent of the brain and of isolated cerebral trssues, and its relationship to the generation of adenosine 2′,5′-cyclic monophosphate Biochem J 164, 131–137.

Newman M. E., Pate1 J., and McIlwain H. (1980) The binding of adenosine to synaptosomal and other preparations from mammalian brain Biochem J. 194, 611–620.

Nimit Y., Law J., and Daly J. W. (1982) Binding of 2′,5′-drdeoxyadenosine to brain membranes. Comparison to P-site inhibltion of adenylate cyclase Biochem Pharmacol 31, 3279–3287.

Nyhan W. C (1973) The Lesch-Nyhan Syndrome Ann. Rev. Med 24, 41–60.

Okada Y. and Saito M. (1979) Inhibitory actions of adenosine, 5HT (serotonm), and GABA (γ-aminobutyric acid) on the postsynaptic potential (PSP) of slices from olfactory cortex and superior colliculus in correlation to the level of cyclic AMP. Brain Res. 160, 368–371.

Olssen R. A. (1984) Structure of the coronary artery adenosine receptor Trends Pharmacol Sci. 5, 113–116

Osswald H. (1983) Adenosine and Renal Function, in Regulatory Function of Adenosine (Berne R. M., Rall T. W., and Rubio R, eds ) pp. 399–415, Martinus Nijhoff, Boston

Paazlow G and Paazlow C (1973) The effects of caffeine and theophylline on nociceptive stimulation in the rat. Acta. Pharmacol Toxicol 32, 22–32

Partington C. R., Edwards M. N., and Daly J W (1980) Calcium-dependent desensitization of adenylate cyclase in rat cerebral cortrcal slices. J Neurochem 34, 76–82

Pate1 J., Marangos P J, Strvers J, and Goodwin F. K (1982) Characterrzation of adenosine receptors in brain using N⁶-cyclohexyl-[³H]adenosine Brain Res. 237, 203–214.

Persson C G. A. (1984) The Pharmacology of Antiasthmatic Xanthines and the Role of Adenosine, in Asthma Reviews (Moley J, ed ) Academic Press, in press.

Phillis J. W. (1984) Antagonism of the actions of psychoactive agents by caffeine Prog. Neurobiol and Biol. Psychiatry. 8, 494–502.

Phillis J W and Wu P. H (1981) The role of adenosine and its nucleotides in central synaptic transmission, Progr. Neurobiol. 16, 187–193.

Phillis J. W. and Wu P. H. (1983) The Role of Adenosine in Central Neuromodulation, in Regulatory Fuction of Adenosine (Berne R. M., Rall T. W., and Rubio R., eds.) pp 419–437, Martinus Nijhoff, Boston.

Phillis J. W., Edstrom J. P., Kostopoulos G. K., and Kirkpatrick J. R. (1979) Effects of adenosine and adenine nucleotides on synaptic transmission in the cerebral cortex. Can J. Physiol Pharmacol 57, 1289–1312.

Phillis J W, Jiang Z G, Chelack B. J., and Wu P H. (1980) The effect of morphine on purine and acetylcholine release from rat cerebral cortex Evidence for a purinergic component in morphine’s action, Pharmacol. Biochem. Behav. 13, 421–427

Polmar S.H, Birch R. E., Mandle R., and Rudolph S. A (1983) Adenosine and Cyclic Nucleotides in Modulation of Immune Responses, in Regulatory Function of Adenosine. (Berne R M., Rall T. W., and Rubio R., eds.) pp. 249–259, Martinus Nijhoff, Boston.

Pons F., Bruns R F, and Daly J. W (1980) Depolarization-evoked accumulation of cycbc AMP in brain slices the requisite Intermediate adenosine is not derived from hydrolysis of released ATP. J Neurochem. 34, 1319–1323

Potter P and White T D (1980) Release of adenosine 5′-triphosphate from synaptosomes from different regions of rat brain. Neuroscience 5, 1351–1356

Premont J., Perez M., and Bockaert J. (1977) Adenosine-sensitive adenyl-ate cyclase in rat striatal homogenates and its relationship to dopamine and Ca²⁺-sensitive adenylate cyclase Mol. Pharmacol 13, 662–670.

Premont J., Perez M., Blanc G., Tarsin J. P., Thierry A. M., Herve D, and Bockaert J (1979) Adenosine-sensitive adenylate cyclase in rat brain homogenates: kinetic characteristics, specificity, topographical, subcellular, and cellular distribution Mol Pharmacol 16, 790–804.

Proctor W. R. and Dunwiddie T. V. (1984) Behavioral sensitivity to purinergic drugs parallels ethanol sensitivity in selectivity bred mice. Science 224, 519–521

Pull I. and McIlwain H. (1974) Rat cerebral cortex adenosine deaminase activity and its subcellular distribution. Biochem J 144, 37–41.

Rabe C. S., and McGee, Jr. R. (1982) The Effects of Methylation Inhibitors on Depolarization-Dependent Exocytosis, Phospholipid Methylation, and Protein Carboxymethylation in Clonal Pheochromocytoma Cells, in The Biochemistry of S-Adenosyl-Methionine and Related Compounds (Usdin E, Borchardt R T, and Creveling C R., eds.) MacMillan, London.

Rabe C. S. and McGee, Jr. R. (1983) Regulation of depolarization-dependent release of neurotransmitter by adenosine: cychc AMP-dependent enhancement of release from PC 12 cells. J Neurochem 41, 1623–1634.

Rabe C S., Willlams T P., and McGee Jr. R. (1980) Enhancement of depolarization-dependent release of norepinephrine by inhibition of S-adenosylmethionine-dependent transmethylation. Life Sci. 27, 1573–1579

Radulovacki M., Virus R M., Djuricic-Nedelson M., and Green R. D. (1983) Hypnotic effects of deoxycoformycin in rats Brain Res. 271, 392–395.

Radulovacki M, Virus R M., Djuricic-Nedelson M., and Green R. D. (1984) Adenosine analogs and sleep in rats. J. Pharmacol. Exp Ther 228, 268–274

Rall T. W. (1980) Central Nervous Stimulants. The Xanthines, in The Pharmacological Basis of Therapeutics (6th Ed.) (Gilman A. G., Goodman L. S., and Gilman A, eds ) pp. 592–607, MacMillan, New York

Reddington M. and Schubert P (1979) Parallel investigations of the effects of adenosine on evoked potentials and cyclic AMP accumulation in hippocampus slices of rat. Neurosci Lett. 14, 37–42.

Reddington M., Lee K., and Schubert P. (1982) An A-1 adenosine receptor, characterized by [³H]cyclohexyladenosine binding, mediates the depression of evoked potentials in a rat hippocampal slice preparation Neurosci Lett 28, 275–279

Reinhard, Jr. J. F., Galloway M. P., and Roth R H. (1983) Noradrenergic stimulation of serotonin synthesis and metabolism. II. Stimulation by 3-isobutyl-1-methylxanthine. J. Pharmacol. Exp Ther. 226, 764–769.

Riberio J A. (1982) The decrease of neuromuscular transmission by adenosine depends on previous neuromuscular depression. Arch Int Pharmacodyn. 255, 59–67.

Riberio J. A., Sa-Almedia A. M, and Namordo J. M. (1979) Adenosine and adenosine triphosphates decrease ⁴⁵Ca²⁺ uptake by synaptosomes stimulated by potassium. Biochem. Pharmacol. 28, 1297–1300.

Rosenberg R. S., Zepelin H., and Rechtschaffen A. (1979) Sleep in young and old rats. J. Gerontol. 34, 525–532.

Sattin A (1981) Adenosine as a Mediator of Antidepressant Treatment, in Chemisms in the Brain. (Rodnight R., Bachelard H S, and Stahl W. S, eds.) pp 265–275, Churchill-Livingston, Edinburgh

Sattin A. and Rall T W. (1970) The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′,5′-phosphate content of guinea pig cerebral cortex slices Mol. Pharmacol. 6, 12–23

Sattin A., Stone T. W, and Taylor D. A. (1978) Biochemical and electrophysiological studies with tricyclic antidepressants in rat and guinea pig cerebral cortex. Life Sci 23, 2321–2626.

Sawynok J. (1983) Theophylline-induced potentiation of the anti-nociceptive action of baclofen. Brit J Pharmacol. 78, 353–357

Sawynok J. and Jhamandas K. H. (1976) Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides, and morphine: antagonism by theophylline. J. Pharmacol Exp Ther 197, 379–390.

Schrader J., Rubio R., and Berne R. M. (1975) Inhibition of slow action potentials of guinea pig atria1 muscle by adenosine. A possible effect on Ca²⁺ influx J Mol. Cell. Cardiol 7, 427–433.

Schubert P. and Mitzdorf V. (1979) Analysis and quantitative evaluation of the depressive effect of adenosine on evoked potentials in hippocampal slices. Brain Res. 172, 186–190

Schubert P., Komp W., and Kreutzberg G. W. (1979) Correlation of 5′-nucleotidase activity and selective transneuronal transfer of adenosine in the hippocampus. Brain Res 168, 419–424.

Schwabe U., Kiffe H, Puchstein C., and Trost T (1979) Specific binding of [³H]adenosine to rat brain membranes. Naunyn-Schmiedeberg’s Arch. Pharmacol. 313, 59–67.

Schwabe U. and Trost T. (1980) Characterization of adenosine receptors in rat brain by (-)-[³H]-N⁶-phenylisopropyladenosine. Naunyn-Schmeideberg’s Arch. Pharmacol 313, 179–188.

Scott T. G. (1967) The distribution of 5′-nucleotidases in the brain of the mouse J Comp Neural. 129, 97–113

Segal M. (1982) Intracellular analysis of a postsynaptic action of adenosine in the rat hippocampus. Eur J Pharmacol. 79, 193–199

Shallaby I. A., Freedman S. B, and Miller R. J. (1983) The effect of organic calcium antagonists on release of [³H]dopamine from aggregate cultures of midbrain neurons. Soc. Neurosci. Abstr. 9, 565.

Shimizu H., Tanaka S., and Kodama T. (1972) Adenosine kinase of mammalian brain: partial purification and its role for the uptake of adenosine. J. Neurochem 19, 687–698.

Shimizu H. (1979) Biochemical Characterization of Adenosine Receptors in the Brain, in Physiological and Regulatory Function of Adenosine and Adenine Nucleotides (Baer H. P and Drummond G I, eds ) pp. 243–248. Raven, New York.

Siggins G. R. and Schubert P. (1981) Adenosine depression of hippocampal neurons in vitro an intracellular study of dose-dependent actions on synaptic and membrane potentials. Neurosci. Lett 23, 55–60

Skolnick P. and Daly J. W (1974) The accumulation of adenosine 3′,5′-monophosphate in cerebral cortical slices of the quaking mouse, a neurological mutant. Brain Res. 73, 513–525.

Skolnick P. and Paul S M. (1981) The mechanism(s) of action of the benzodiazepines. Med. Res. Rev. 1, 3–22

Skolnick P., Lock K. C., Paul S. M., Marangos P. J,, Jones R., and Irmscher K. (1980) Increased benzodiazepine receptor number elicited in vitro by a novel purine EMD 28422 Eur. J. Pharmacol. 67, 179–186.

Smellie F. W, Davis C W, Daly J. W, and Wells J N. (1979) Alkylxanthines—inhibition of adenosine-elicited accumulation of cyclic-AMP in brain slices and of brain phosphodiesterase activity Life Sci. 24, 2475–2481

Snell P. H. and Snell C. R. (1983) [³H] Adenosine binding sites on 108CC15 neuroblastoma × glioma hybrid cell line and rat brain membranes. Neurochem. Int. 5, 245–249.

Snyder S. H (1985) Adenosine as a neuromodulator. Ann Rev Neurosci. 8, 103–124.

Snyder S. H., Katims J. J., Annau Z., Bruns R F., and Daly J. W. (1981) Adenosine receptors and behavioral actions of methylxanthines Proc. Natl. Acad. Sci. USA 78, 3260–3764.

Snyder S. H., Braas K. M., and Newby A. C (1984) Immunocytochemical localization of adenosine-containing neurons in rat brain. Proc. Intl. Life Sci Inst. Meeting. Mexico, June, 1984, in press

Spencer D. G., Gherezghiher T., and Lal H. (1984) Inosine and N⁶-substituted adenosine analogs lack anxiolytic activity in the pentylenetetrazol discrimmation model of anxiety Drug Develop Res. 4, 201–206.

Spignoli G., Pedata F., and Pepeu G. (1984) A₁ and A₂ adenosine receptors modulate acetylcholine relase from brain slices. Eur. J. Pharmacol. 97, 341–342.

Standaert F. G. and Dretchen K. L. (1979) Cyclic nucleotides and neuromuscular transmission. Fed. Proc 38, 2183–2192

Stone T. W. (1981) Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neurosci. 6, 523–525

Stone T. W. (1983) Interaction of Adenosine with Other Agents, in Regulatoy Function of Adenosine (Berne R. M., Rall T. W., and Rubio R., eds ) pp. 467–477. Martinus Nijhoff, Boston.

Stone T. W. (1985) Purines: Pharmacology and Physiological Roles MacMillan, London

Stone T. W. and Taylor D. A. (1978) Clonidine as an adenosine agonist. J. Pharmacol. 30, 792–793.

Stone T. W and Taylor D. A. (1979) Antidepressant drugs potentiate supression by adenosine of neuronal firing in rat cerebral cortex. Neurosci Lett. 11, 93–97

Sugrue M. F. (1981) Chronic antidepressant administration and adaptive changes in central monoaminergic systems, in Antidepressants Neurochemical, Behavioral, and Clinical Perspectives (Enna S. J., Malick J B., and Richelson E., eds ) pp. 13–30, Raven, New York.

Sun M-C, McIlwain H., and Pull I (1976) The metabolism of adenine derivatives in different parts of the brain of the rat and their release from hypothalamic preparations in excitation. J Neurobiol 7, 109–122.

Thithapandha A., Maling H. M, and Gillette G. R (1972) Effects of caffeine and theophylline on activity of rats in relation to brain xanthine concentration. Proc. Soc. Exp. Biol. Med 139, 582–586.

Trams E. G and Lauter C. J. (1974) On the sidedness of plasma membrane enzymes. Biochem Biophys. Acta 345, 180–197.

Van Calker D., Muller M, and Hamprecht B. (1978) Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells Nature (Lond. ) 276, 839–841

Van Calcker D., Muller M., and Hamprecht B. (1979) Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells J Neurochem. 33, 999–1005

Vapaatalo H., Onken D., Neuvonen P., and Westerman E (1975) Stereo-specificity in some central and circulatory effects of phenylisopropyl-adenosine (PIA) Arnzeim Forsch 25, 407–410.

Vellucci S. V and Webster R A. (1984) Antagonism of caffeine-induced seizures in mice by Ro 15-1788. Eur. J. Pharmacol. 97, 289–293.

Virus R. M., Baglajewski T, and Radulovacki M. (1984) [³H]-N⁶-(L-Phenylisopropyl) adenosine binding in brain from young and old rats. Neurobiol Aging 5, 61–62.

Wagner J. A. and Katz R. J. (1983) Purinergic control of anxiety. direct behavioral evidence in rat Neurosci Lett. 43, 333–337.

Watanabe Y, Lai R. T., and Yoshlda H (1983) Increase of [³H]clonidine binding sites induced by adenosine receptor agonists in rat vas deferens in vitro. Eur J Pharmacol 86, 265–269

Weller M (1977) Evidence for the presynaptic location of adenylate cyclase and the cyclic-AMP stimulated protein kinase which is bound to synaptic membranes Biochem Biophys. Acta 409, 350–345.

White C, Lincoln C. A, and Pearce N W. (1980) Anxiety and muscle tension as consequences of caffeine withdrawal. Science 209, 1547–1548.

Williams M. (1981) Purinergic Receptors in Mammalian Brain. Characterization by Ligand Binding Techniques, in Chemisms in the Brain (Rodnight R., Bachelard H S., and Stahl W. S., eds ) pp. 88–99, Churchill-Livingstone, Edinburgh.

Williams M. (1983) Anxioselective anxiolytics J Med Chem 26, 619–628.

Williams M. (1984a) Mammalian Central Adenosine Receptors, in Handbook of Neurochemistry. vol 6 (Lajtha A., ed.) pp 1–26, Plenum, New York.

Williams M. (1984b) Adenosine—a selective neuromodulator in the CNS? Trends Neurosci 7, 164–168

Williams M. and Risley E A. (1980a) Biochemical characterization of putative purinergic receptors by using 2-chloro-[³H]adenosine, a stable analog of adenosine. Proc. Natl. Acad Sci USA 77, 6892–6896.

Williams M., and Risley E. A. (1980b) Binding of ³H-adenyl-5′-imidodi-phosphate (AppNHp) to rat brain synaptic membranes. Fed. Proc 39, 1009.

Williams M. and U’Prichard D. C. (1984) Drug discovery at the molecular level a decade of radioligand binding in retrospect. Ann. Rep. Med Chem. 19, 283–292

Williams M. and Valentine H. (1985) Binding of [³H]cyclohexyladenosine (CHA) to adenosine recognition sites in guinea pig ileal membranes: comparison with binding in brain membranes, Neurosci. Lett. 57, 79–83.

Williams M. and Wood P. L. (1981) Effect of chronic chemical and surgical denervation on A-1 adenosine receptor density in rat brain. Pharmacologist 23, 184.

Williams M., Risley E. A., and Huff J. R. (1981) Interaction of putative anxiolytic agents with central adenosine receptors Can. J Physiol Pharmacol. 59, 897–900.

Williams M., Risley E A., and Robinson J L. (1983) Chronic in vivo treatment with desmethylimipramine and mianserin does not alter adenosine A-1 radioligand binding in rat cortex. Neurosci. Lett. 35, 47–51

Wojcik W J. and Neff N H. (1982) Adenosine measurement by a rapid HPLC-fluorometric method: Induced change of adenosine content in regions of rat brain. J. Neurochem. 39, 280–282.

Wojcik W. J. and Neff N. H. (1983a) Adenosine A₁ receptors are associated with cerebellar granule cells. J Neurochem. 41, 759–763.

Wojcik W. J. and Neff N. H. (1983b) Differential location of adenosine A₁ and A₂ receptors in strratum Neurosci. Lett. 41, 55–60.

Wojcik W. J. and Neff N. H (1983c) Location of adenosine release and adenosine A₂ receptors to rat striatal neurons Life Sci. 33, 755–763

Wooten F. G., Thoa N. B., Kopin I. J., and Axelrod J. (1973) Enhanced release of dopamme-β-hydroxylase and norepinephrine from sympathetic nerves by dibutyryl cychc adenosine monophosphate and theophylline. Mol. Pharmacol. 9, 178–183.

Wu P H. and Coffin V. L (1984) Up-regulation of brain [³H]diazepam binding sites in chronic caffeine-treated rats. Brain Res. 294, 186–189.

Wu P. H. and Phillis J. W. (1982) Adenosine receptors in rat brain membranes: characterization of high affinity binding of [³H]-2-chloroadenosine Int. J Biochem 14, 399–404.

Wu P. H., Phillis J. W, Balls K., and Rinaldi B. (1980) Specific binding of 2-[³H]-chloroadenosine to rat brain cortical membranes Can J Physiol. Pharmacol. 58, 576–579.

Wybenga M. P., Murphy M. G., and Robertson H. A. (1981) Rapid changes in cerebellar adenosine receptors followmg experimental seizures. Eur J. Pharmacol. 75, 79–80.

Yarbrough G.G. and McGuffin-Clineschmidt J. (1981) In viva behavioral assessment of central nervous system purinergic receptors. Eur. J. Pharmacol. 76, 137–144.

Yeung S. M. H. and Green R D. (1983) Agonist and antagonist affinities for inhibitory adenosine receptors are reciprocally affected by 5′-guanylylimidodiphosphate or N-ethylmaleimide. J. Biol. Chem. 258, 2334–2339.

Yeung S M. H. and Green R. D. (1984) [³H]-5′-N-ethylcarboxamide adenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn-Schmiedeberg’s Arch. Pharmacol 325, 218–225

Comments (Loading...)

Post comment/View all comments